Profile
Matthew B. Lehman is currently Chief Executive Officer at Koligo Therapeutics, Inc., and a member of the Association of Clinical Research Professionals and the European Business Association.
Formerly, Mr. Lehman was President, Chief Executive Officer & Director at Callitas Health, Inc. from 2015 to 2016; Chief Executive Officer, MD & Executive Director at Immutep Ltd. from 2013 to 2014; Chief Executive Officer & Executive Director at Koligo Therapeutics Ltd.; and Chief Operating Officer at SPRI Clinical Trials-Global LLC.
Education includes graduate studies at The Trustees of Columbia University in The City of New York and undergraduate studies at the University of Louisville.
Matthew Lehman active positions
| Companies | Position | Start |
|---|---|---|
European Business Association | Corporate Officer/Principal | 03/01/2011 |
Association of Clinical Research Professionals
Association of Clinical Research Professionals Miscellaneous Commercial ServicesCommercial Services Operates as a association of clinical research professionals | Corporate Officer/Principal | 03/01/2011 |
Koligo Therapeutics, Inc.
Koligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes transformative cell therapies for the treatment of pancreatic diseases | Chief Executive Officer | - |
Former positions of Matthew Lehman
| Companies | Position | End |
|---|---|---|
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops, manufacture, and sells transformative cell therapies for the treatment of pancreatic diseases | Chief Executive Officer | 18/02/2021 |
| CALLITAS HEALTH INC. | Chief Executive Officer | 15/03/2016 |
| IMMUTEP LIMITED | Chief Executive Officer | 09/07/2014 |
SPRI Clinical Trials-Global LLC
SPRI Clinical Trials-Global LLC Miscellaneous Commercial ServicesCommercial Services Engages in clinical research | Chief Operating Officer | - |
Training of Matthew Lehman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Callitas Health, Inc.
Callitas Health, Inc. Pharmaceuticals: MajorHealth Technology Develops technologies for monitoring and treatment of obesity, diabetes & other gastroenterological indications | Health Technology |
SPRI Clinical Trials-Global LLC
SPRI Clinical Trials-Global LLC Miscellaneous Commercial ServicesCommercial Services Engages in clinical research | Commercial Services |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immutep Ltd.
Immutep Ltd. BiotechnologyHealth Technology Engages in the development of anti-cancer therapeutics | Health Technology |
University of Louisville
University of Louisville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association of Clinical Research Professionals
Association of Clinical Research Professionals Miscellaneous Commercial ServicesCommercial Services Operates as a association of clinical research professionals | Commercial Services |
European Business Association | |
Koligo Therapeutics, Inc.
Koligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes transformative cell therapies for the treatment of pancreatic diseases | Health Technology |
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops, manufacture, and sells transformative cell therapies for the treatment of pancreatic diseases | Health Technology |
- Stock Market
- Insiders
- Matthew Lehman
















